Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 2
2009 1
2010 2
2012 1
2013 1
2014 1
2015 1
2016 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
The business of RNAi therapeutics.
Haussecker D. Haussecker D. Hum Gene Ther. 2008 May;19(5):451-62. doi: 10.1089/hum.2008.007. Hum Gene Ther. 2008. PMID: 18435603 Review. No abstract available.
RNAi Arrives at the Bedside after a Mere Two Decades.
Haussecker D. Haussecker D. Mol Ther. 2018 Nov 7;26(11):2533-2534. doi: 10.1016/j.ymthe.2018.10.003. Epub 2018 Oct 23. Mol Ther. 2018. PMID: 30366820 Free PMC article. No abstract available.
RNA interference. Drugging RNAi.
Haussecker D, Kay MA. Haussecker D, et al. Science. 2015 Mar 6;347(6226):1069-70. doi: 10.1126/science.1252967. Science. 2015. PMID: 25745148 Free PMC article. No abstract available.
Turnover and function of noncoding RNA polymerase II transcripts.
Dye MJ, Gromak N, Haussecker D, West S, Proudfoot NJ. Dye MJ, et al. Among authors: haussecker d. Cold Spring Harb Symp Quant Biol. 2006;71:275-84. doi: 10.1101/sqb.2006.71.040. Cold Spring Harb Symp Quant Biol. 2006. PMID: 17381307 Review.
The Business of RNAi Therapeutics in 2012.
Haussecker D. Haussecker D. Mol Ther Nucleic Acids. 2012 Feb 7;1(2):e8. doi: 10.1038/mtna.2011.9. Mol Ther Nucleic Acids. 2012. PMID: 23344723 Free PMC article. No abstract available.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page